Old Web
English
Sign In
Acemap
>
authorDetail
>
Kumi Koide
Kumi Koide
Astellas Pharma
Medicine
Tacrolimus
Steatosis
Steatohepatitis
Nonalcoholic fatty liver disease
3
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Physiologically-based pharmacokinetic modeling and simulation of drug-drug interactions between azole antifungals, macrolide antibiotics or proton pump inhibitors and tacrolimus for provision of quantitative information to clinical practice
2018
Yukio Otsuka
Akira Koibuchi
Atsunori Kaibara
Yukako Tsukamoto
Kumi Koide
Kazuya Iwamoto
Masato Yamazaki
Manabu Murakami
Naoko Sato
Show All
Source
Cite
Save
Citations (0)
ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model
2017
Transplant Immunology
Hao Dun
Lijun Song
Anlun Ma
Yanxin Hu
Lin Zeng
Jieying Bai
Guangzhou Zhang
Liangyan Zhang
Kumi Koide
Yohei Okada
Kaori Hanaoka
Rie Yamamoto
Jun Hirose
Tatsuaki Morokata
Pierre Daloze
Huifang Chen
Show All
Source
Cite
Save
Citations (5)
Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats
2015
European Journal of Pharmacology
Yuka Hayashizaki-Someya
Eiji Kurosaki
Toshiyuki Takasu
Hikaru Mitori
Shunji Yamazaki
Kumi Koide
Shoji Takakura
Show All
Source
Cite
Save
Citations (81)
1